Guidance - Spark Newswire

The Vita Coco Company Expects sales growth of approximately of 9-11% compared to fiscal year 2022, with Vita Coco Coconut Water expected to grow mid-teens and Private Label net sales approximately

COCO

1 minute read

REV Group Reaffirms FY23 Sales Outlook Of $2.3B-$2.5B Vs. $2.37B Estimate

By Benzinga Newsdesk

Today, 12:40 PM

Adjusted EBITDA of $110-$130 million, and Adjusted Net Income of $42-$60 million; Updates outlook for net income to $13-$32 million

REVG

1 minute read

Life Time Expects Q1 FY23 Sales Of $505M-$510M Vs. $509.8M Estimate; Reiterates FY23 Revenue Guidance Of $2.2B-$2.3B Vs. $2.25B Estimate

By Benzinga Newsdesk

Today, 12:40 PM

Adjusted EBITDA For Q1 FY23 Expected To Be $108M-$110M. Adjusted EBITDA For FY23 is Expected To Be $440M-$4600M. Other 2023 Outlook Items Plans to open 10 athletic country clubs in

LTH

1 minute read

Adidas Q4 Revenue Declines 1%, Slashes Dividend By 78% Amid Kanye West Split Impact

By Shivani Kumaresan

Today, 12:40 PM

Adidas AG (OTC:ADDYY) reported a 1% decline in currency-neutral revenues for fourth-quarter FY22. The decrease in revenue was due to…

ADDYY

1 minute read

What’s Going On With Globalstar Stock?

By Henry Khederian

Today, 12:40 PM

Globalstar, Inc. (NASDAQ: GSAT) shares are trading flat at $1.20 during Tuesday's after-hours session after the company announced it had

GSAT

1 minute read

Globalstar Says Reaffirmed Previously Issued Revenue Guidance For FY23

By Michael Horton

Today, 12:40 PM

-SEC Filing

GSAT

1 minute read

Aquestive Therapeutics Sees FY23 Revenue $37M-$41M Vs $37.83M Est.

By Happy Mohamed

Today, 12:40 PM

2023 Outlook Aquestive is providing its full year 2023 financial outlook. The Company expects: Guidance Total revenue (in millions) $37 to $41 Non-GAAP adjusted EBITDA

AQST